Michael J Schell

11PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMedical infection agents (incl. prions)Engineering electromagnetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|May 04, 2026
Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention.

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Oct 03, 2025
Persistence and clearance of oral human papillomavirus among a multi-national cohort of men.

Brittney L Dickey, Racheal S Dube Mandishora, Bradley Sirak

|Sep 19, 2025
A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint Inhibitors.

Nathan H Parker, Jairo D Ramos, Ahmad A Tarhini

|Dec 10, 2024
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer.

Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva

Pageof 2

Frequent Collaborators

4 joint publications

Anna R Giuliano

3 joint publications

Vernon K Sondak

2 joint publications

Antonio L Amelio

2 joint publications

Christine H Chung